Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
LeMaitre Vascular, Inc. LMAT
$65.05
-$0.12 (-0.18%)
На 18:00, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
1450353400.00000000
-
week52high
68.06
-
week52low
39.67
-
Revenue
161651000
-
P/E TTM
72
-
Beta
0.98615900
-
EPS
0.93000000
-
Last Dividend
0.56000000
-
Next Earnings Date
26 июл 2023 г. в 10:59
Описание компании
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Jefferies | Buy | 16 сент 2021 г. | |
| Roth Capital | Neutral | Neutral | 03 авг 2021 г. |
| Roth Capital | Neutral | Neutral | 04 мая 2021 г. |
| KeyBanc | Sector Weight | 12 февр 2021 г. | |
| Roth Capital | Neutral | Neutral | 30 окт 2020 г. |
| Barrington Research | Market Perform | Outperform | 28 окт 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Roberts David B | D | 14108 | 3195 | 06 янв 2023 г. |
| Roberts David B | A | 19937 | 3195 | 06 янв 2023 г. |
| O'Connor John James | D | 48954 | 5555 | 27 дек 2022 г. |
| Kamke Trent G | D | 10031 | 54 | 22 дек 2022 г. |
| Roberts David B | D | 0 | 17 | 22 дек 2022 г. |
| Roberts David B | D | 16742 | 132 | 22 дек 2022 г. |
| Roberts David B | A | 16874 | 17 | 22 дек 2022 г. |
| Pellegrino Joseph P JR | D | 0 | 17 | 22 дек 2022 г. |
| Pellegrino Joseph P JR | D | 7762 | 192 | 22 дек 2022 г. |
| Pellegrino Joseph P JR | A | 7954 | 17 | 22 дек 2022 г. |
Новостная лента
What Makes LeMaitre Vascular (LMAT) a Strong Momentum Stock: Buy Now?
Zacks Investment Research
10 мая 2023 г. в 13:41
Does LeMaitre Vascular (LMAT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why Shares of LeMaitre Vascular Are Up Wednesday
The Motley Fool
03 мая 2023 г. в 13:56
LeMaitre credited a beefed-up sales force and an uptick in hospital orders for higher numbers. The company grew revenue by 19% year over year in the first quarter.
LeMaitre Vascular, Inc. (LMAT) Q1 2023 Earnings Call Transcript
Seeking Alpha
02 мая 2023 г. в 22:10
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q1 2023 Earnings Conference Call May 2, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Financial Officer George LeMaitre - Chairman and Chief Executive Officer David Roberts - President Conference Call Participants Brett Fishbin - KeyBanc Capital Markets Inc. Frederick Wise - Stifel, Nicolaus & Company, Inc. Michael Petusky - Barrington Research Associates, Inc. Scott Henry - ROTH Capital Partners Operator Welcome to the LeMaitre Vascular Q1 2023 Financial Results Conference Call. As a reminder, today's call is being recorded.
ZBH or LMAT: Which Is the Better Value Stock Right Now?
Zacks Investment Research
26 апр 2023 г. в 12:54
Investors with an interest in Medical - Products stocks have likely encountered both Zimmer Biomet (ZBH) and LeMaitre Vascular (LMAT). But which of these two stocks offers value investors a better bang for their buck right now?
Income Investors: These 2 Stocks Have Quadrupled Their Dividend Payouts Over the Past 10 Years
The Motley Fool
06 апр 2023 г. в 05:44
Amgen and LeMaitre Vascular both possess solid product portfolios and pipelines to drive future earnings growth. Their payouts are well-covered by their earnings.